The New Psychedelic Stocks Index Declined 5.4% This Past Week

This article tracks the weekly performance of 11 of 31 stocks involved in the research and development of psychedelic compounds to treat mental health issues such as OCD, PTSD, opioid and alcohol addiction, depression, anxiety, and eating disorders.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.